FDA authorizes updated COVID shots with restrictions on who can get them
The Food and Drug Administration rescinded the emergency use authorization that made COVID-19 shots available for healthy children under 5 years old.
Watch CBS News
The Food and Drug Administration rescinded the emergency use authorization that made COVID-19 shots available for healthy children under 5 years old.
New COVID-19 vaccines have arrived at pharmacies in the Bay Area, designed to target the most recent FLiRT variants that have become dominant this summer. Sooji Nam reports. Website: http://kpix.com/ YouTube: http://www.youtube.com/CBSSanFrancisco Facebook: https://www.facebook.com/CBSSanFrancisco Instagram: https://www.instagram.com/kpixtv/ Twitter: https://twitter.com/KPIXtv
Federal health officials say thousands of updated booster shots are already being shipped around the country.
The first shots in the Biden administration's fall booster campaign could start in days, after a vote by the CDC's advisers.
Pfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic.
The agency also upped its recommendation for second boosters in adults 50 and older, as well as the immunocompromised.
A rise in new COVID-19 cases among children was reported overnight by health leaders, but there may be extra protection coming for those children in the form of booster doses of vaccines.
A rise in new COVID-19 cases among children was reported overnight by health leaders but there may be extra protection coming for those children in the form of booster doses of vaccines. Andrea Nakano reports. (5-17-22)
The U.S. Food and Drug Administration has delayed a meeting about a COVID-19 vaccine for children younger than 5 that was originally scheduled to take place next week.
In a major development in the race to get the COVID-19 vaccine out to the youngest children by the end of February, Pfizer is seeking emergency use authorization for a two dose vaccine for kids 0-5 years old.
Kaiser Permanente has alerted nearly 4,000 of its members who received a Pfizer COVID vaccine at its Walnut Creek Medical Center that they may have received less than a full dose.
Millions of Americans as young as 12 could soon be able to get a booster shot of COVID-19 vaccine, after the Food and Drug Administration announced Monday that it has authorized third doses of Pfizer-BioNTech's shot for that age group.
The Food and Drug Administration announced Wednesday it has greenlighted Pfizer's antiviral pills to treat COVID-19 for emergency use, allowing limited use of the drug in Americans as young as 12 who are at "high risk for progression to severe COVID-19."
Pfizer announced Tuesday it is asking the U.S. Food and Drug Administration to authorize booster doses of its COVID-19 vaccine for all adults, ages 18 and older.
Pfizer's Friday announcement that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults could be a game changer in the treatment of the virus. At least that was initial opinion of UCSF Professor of Medicine and Infections Disease Dr. Monica Gandhi.
The CDC issued formal recommendations Tuesday for children as young as 5 years old to get vaccinated against COVID-19, clearing the final regulatory hurdle for younger kids to start receiving Pfizer's vaccine this week.
The Food and Drug Administration on Friday authorized a smaller dose of Pfizer's COVID-19 vaccine for children ages 5 to 11, a critical step for the more than 28 million children that may soon be eligible.
Pfizer's request to roll out COVID-19 vaccines for Americans as young as 5 years old cleared a key regulatory hurdle Tuesday, after a panel of the Food and Drug Administration's outside vaccine advisers voted by a majority to back Pfizer's request.
More potentially damaging testimony against Elizabeth Holmes came on Friday in the Theranos fraud trial.
Kid-size doses of Pfizer's COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
The U.S. Food and Drug Administration is expected to authorize boosters for Moderna and Johnson & Johnson -- and perhaps even more anticipated for some -- allow for the mix-and-match of the vaccines.
Johnson & Johnson announced Tuesday that booster shots given two months after the first dose increased protection against the virus to 94 percent- comparable to Pfizer and Moderna.
There was good news Monday morning for San Francisco Bay Area parents worried about the safety of their children from COVID-19 in the classroom. Pfizer says its vaccine works for children ages 5 to 11 and will seek FDA approval to begin administering the shots.
A panel of the Food and Drug Administration's vaccine advisers voted unanimously Friday in favor of an emergency use authorization for a third dose of Pfizer's COVID-19 vaccine, six months after some Americans completed their first two doses.
Bay Area public health officials are hoping the U.S. Food and Drug Administration's full approval of the Pfizer COVID vaccine will convince the hesitant and the holdouts to get their shot.
